Skip to main content
HR 7069 117th Congress House Health Advisory bodies Asia Cardiovascular and respiratory health Chemical and biological weapons China Congressional operations and organization Congressional oversight Disability and health-based discrimination Emergency medical services and trauma care Government studies and investigations Health facilities and institutions Health personnel Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Immunology and vaccination Infectious and parasitic diseases Intelligence activities, surveillance, classified information International organizations and cooperation

National Commission on the COVID–19 Pandemic Act

Introduced: March 11, 2022 See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 14, 2022
Referred to the Subcommittee on Health.
Mar 11, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 11, 2022
Introduced in House
 Plain-English summary Congressional Research Service

National Commission on the COVID-19 Pandemic Act

This bill temporarily establishes the National Commission on the COVID-19 Pandemic in the legislative branch to investigate the facts and circumstances regarding the emergence of, spread of, and response to COVID-19. The commission terminates 90 days after it submits a final report of its findings and recommendations.

What's happening now March 14, 2022

Referred to the Subcommittee on Health.

 Committees of jurisdiction 3